FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
10 letters match. Newest first.
-
BiologicsCalibrate IV Hydration
FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.
High risk -
BiologicsBeaute Bounty
FDA warns Beaute Bounty that its stem cell and placenta products are unapproved drugs and unlicensed biologics.
High risk -
BiologicsNexCell Scientific Inc
NexCell Scientific markets an unapproved, unlicensed umbilical cord blood cell product with serious manufacturing violations.
High risk -
BiologicsR3 Medical Companies
FDA cites R3 Medical affiliates for selling unapproved umbilical cord and exosome biologics without licenses and with serious manufacturing violations.
High risk -
BiologicsBlue Horizon International, LLC
FDA warned Blue Horizon International over unapproved stem cell and exosome biologics marketed for serious diseases without a license.
High risk -
BiologicsDynamic Stem Cell Therapy
FDA warned Dynamic Stem Cell Therapy that its umbilical cord-derived stem cell product is an unapproved, unlicensed, misbranded biological drug.
High risk -
BiologicsCelularity, Inc
Unapproved New Drug/Unlicensed Biological Product/Biologics License Application (BLA)
-
BiologicsBioXtek LLC
Unapproved New Drug/Unlicensed Biological Product/Biologics License Application (BLA)
-
BiologicsLux Therapeutics LLC dba Ponya Therapeutics LLC
Unapproved New Drug/Unlicensed Biological Product/Biologics License Application (BLA)
-
BiologicsFrontier Biologics, LLC
Unapproved New Drug/Unlicensed Biological Product Violations